Page last updated: 2024-08-23

1-deoxynojirimycin and aspirin

1-deoxynojirimycin has been researched along with aspirin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Itoh, K; Tsuji, D1
Allocca, M; Andreotti, G; Bosso, A; Cubellis, MV; Hay Mele, B; Liguori, L; Lukas, J; Monti, MC; Monticelli, M; Morretta, E1

Reviews

1 review(s) available for 1-deoxynojirimycin and aspirin

ArticleYear
[Molecular pathogenesis and therapeutic targets of lysosomal diseases].
    Seikagaku. The Journal of Japanese Biochemical Society, 2007, Volume: 79, Issue:7

    Topics: 1-Deoxynojirimycin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-N-Acetylhexosaminidases; Bone Marrow Transplantation; Disease Models, Animal; G(M2) Activator Protein; Genetic Therapy; Humans; Lysosomal Storage Diseases, Nervous System; Mutation

2007

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and aspirin

ArticleYear
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones.
    International journal of molecular sciences, 2022, May-04, Volume: 23, Issue:9

    Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Aspirin; Drug Repositioning; Fabry Disease; Humans; Lysosomes; Molecular Chaperones; Mutation

2022